Strong Buy Do not make a stop Strong Buy Do not make a stop
will get you out of the market
and the price will go off with a strong buy
The company's stock is placed in the portfolio
for medium-term investment
−0.1225 EUR
−6.68 M EUR
7.45 M EUR
87.01 M
About IMPLANET
Sector
Industry
CEO
Ludovic Lastennet
Website
Headquarters
Martillac
Founded
2006
ISIN
FR0013470168
FIGI
BBG005M6P1T9
Implanet SA engages in manufacturing implants designed for orthopedic surgery. Its products include madison, olea, jazz PF, evo, cap sp, passer, lock, claw, frame and ISS-JAZZ Screw System. The company was founded on January 23, 2007 and is headquartered in Martillac, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALIMP is 0.1240 EUR — it has increased by 4.51% in the past 24 hours. Watch IMPLANET stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange IMPLANET stocks are traded under the ticker ALIMP.
ALIMP stock has fallen by −0.39% compared to the previous week, the month change is a −4.49% fall, over the last year IMPLANET has showed a 162.16% increase.
ALIMP reached its all-time high on Sep 19, 2017 with the price of 30.8000 EUR, and its all-time low was 0.0350 EUR and was reached on Dec 6, 2023. View more price dynamics on ALIMP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALIMP stock is 3.23% volatile and has beta coefficient of 2.04. Track IMPLANET stock price on the chart and check out the list of the most volatile stocks — is IMPLANET there?
Today IMPLANET has the market capitalization of 15.93 M, it has increased by 2.00% over the last week.
Yes, you can track IMPLANET financials in yearly and quarterly reports right on TradingView.
ALIMP net income for the last half-year is −1.65 M EUR, while the previous report showed −4.41 M EUR of net income which accounts for 62.53% change. Track more IMPLANET financial stats to get the full picture.
No, ALIMP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMPLANET EBITDA is −4.91 M EUR, and current EBITDA margin is −65.13%. See more stats in IMPLANET financial statements.
Like other stocks, ALIMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMPLANET stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMPLANET technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMPLANET stock shows the sell signal. See more of IMPLANET technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.